» Articles » PMID: 22157761

Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Dec 14
PMID 22157761
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

IL-6 has been shown to play a major role in collagen up-regulation process during cardiac hypertrophy, although the precise mechanism is still not known. In this study we have analyzed the mechanism by which IL-6 modulates cardiac hypertrophy. For the in vitro model, IL-6-treated cultured cardiac fibroblasts were used, whereas the in vivo cardiac hypertrophy model was generated by renal artery ligation in adult male Wistar rats (Rattus norvegicus). During induction of hypertrophy, increased phosphorylation of STAT1, STAT3, MAPK, and ERK proteins was observed both in vitro and in vivo. Treatment of fibroblasts with specific inhibitors for STAT1 (fludarabine, 50 μM), STAT3 (S31-201, 10 μM), p38 MAPK (SB203580, 10 μM), and ERK1/2 (U0126, 10 μM) resulted in down-regulation of IL-6-induced phosphorylation of specific proteins; however, only S31-201 and SB203580 inhibited collagen biosynthesis. In ligated rats in vivo, only STAT3 inhibitors resulted in significant decrease in collagen synthesis and hypertrophy markers such as atrial natriuretic factor and β-myosin heavy chain. In addition, decreased heart weight to body weight ratio and improved cardiac function as measured by echocardiography was evident in animals treated with STAT3 inhibitor or siRNA. Compared with IL-6 neutralization, more pronounced down-regulation of collagen synthesis and regression of hypertrophy was observed with STAT3 inhibition, suggesting that STAT3 is the major downstream signaling molecule and a potential therapeutic target for cardiac hypertrophy.

Citing Articles

Interleukin-6: Molecular Mechanisms and Therapeutic Perspectives in Atrial Fibrillation.

Yu J, Dong Q, Du Y Curr Med Sci. 2025; .

PMID: 40035997 DOI: 10.1007/s11596-025-00021-7.


Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II.

Cui Y, Yang Y, Tang X, Wang P, Cui J, Chen Y Front Pharmacol. 2025; 16:1555991.

PMID: 40028160 PMC: 11868102. DOI: 10.3389/fphar.2025.1555991.


Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.

Dihoum A, Brown A, McCrimmon R, Lang C, Mordi I BMC Cardiovasc Disord. 2024; 24(1):356.

PMID: 38997620 PMC: 11241903. DOI: 10.1186/s12872-024-04022-7.


Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.

Hilgendorf I, Frantz S, Frangogiannis N Circ Res. 2024; 134(12):1718-1751.

PMID: 38843294 PMC: 11164543. DOI: 10.1161/CIRCRESAHA.124.323658.


JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target.

Jiang H, Yang J, Li T, Wang X, Fan Z, Ye Q Front Pharmacol. 2024; 15:1336102.

PMID: 38495094 PMC: 10940489. DOI: 10.3389/fphar.2024.1336102.


References
1.
Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J . Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000; 275(38):29717-23. DOI: 10.1074/jbc.M003128200. View

2.
Podewski E, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert K . Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation. 2003; 107(6):798-802. DOI: 10.1161/01.cir.0000057545.82749.ff. View

3.
Hedayat M, Mahmoudi M, Rose N, Rezaei N . Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev. 2010; 15(6):543-62. DOI: 10.1007/s10741-010-9168-4. View

4.
Sarkar S, Chawla-Sarkar M, Young D, Nishiyama K, Rayborn M, Hollyfield J . Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. J Biol Chem. 2004; 279(50):52630-42. DOI: 10.1074/jbc.M402037200. View

5.
Bueno O, de Windt L, Lim H, Tymitz K, Witt S, Kimball T . The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res. 2001; 88(1):88-96. DOI: 10.1161/01.res.88.1.88. View